Macular Degeneration

Age related macular degeneration is one of the leading causes of blindness in the United States. It is a medical condition which affects older adults that results in a loss of vision in the center of the vision because of damage to the retina. It occurs in “dry” and “wet” forms. It is a major cause of visual impairment in older adults over 50 years of age. Macular degeneration can make it difficult to read or recognize faces, although enough peripheral vision remains to allow other daily activities. Although some degeneration affecting younger individuals are sometimes referred to as macular degeneration, the term generally refers to age-related macular degeneration (AMD or ARMD).

The inner layer of the eye is the retina, which contains nerves that communicate sight, and behind the retina is the choroid which contains the blood supply to the macula. The macula is made up of millions of light-sensing cells that collectively produce central vision. AMD occurs in two forms.

“Dry” AMD – Advances slowly, and may be hardly noticeable. Ninety percent of all people with AMD have this type. Exactly why it develops is not known, but it seems to be caused by aging and thinning of the tissues of the macula. A slow breakdown of the light-sensing cells in the macula leads to a gradual loss of central vision. While there is no current treatment for Dry AMD, there are studies that show Preservision AREDS II can help slow the progression of vision loss.

“Wet” AMD – Although only 10 percent of all people with AMD have this  type, it accounts for 90 percent of all blindness from the disease. As dry AMD worsens, abnormal blood vessels may form underneath the retina. These new blood vessels tend to be very fragile, and will often leak blood and fluid. This causes damage to the overlying retinal tissue, and can lead to rapid and severe loss of central vision. 

Treatment of Macular degeneration

“Dry” AMD- Your doctor will monitor your condition with Dilated eye examinations and Retinal Tissue scanning. Call our office if you have changes in vision or any notable changes when  checking your Amsler grid.

“Wet” AMD- Your doctor will monitor your condition with Dilated eye examinations and Retinal Imaging. There are injections that are given in the eye that can help slow the progression of wet AMD, preventing further vision loss and sometimes even an improvement in vision can be achieved. 


  • Avastin is a drug used to treat wet age-related macular degeneration (AMD). It is injected into the eye to help slow vision loss.

  • Avastin is the brand name for the drug, which is called bevacizumab.

On the day of your injection you will get an anesthetic eye drop to numb the eye and then you will be prepped with Iodine to clean around the eye. Dr. Zablocki will then place a lid speculum in the eye to hold your lids open, he will administer more anesthetic to the injection site making sure you are numb prior to the injection. After the injection there are no restrictions, you may resume normal activity. 

This procedure is done in our office and only takes a few minutes to actually complete. We ask that you plan on being in the office for 1-2 hours the day of your laser treatment.